Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2025-12-25 @ 2:24 PM
NCT ID: NCT01104766
Description: Data is for the Double-blinding treatment period
Frequency Threshold: 5
Time Frame: Assessed over 2 months
Study: NCT01104766
Study Brief: Safety and Efficacy of Cariprazine in Patients With Schizophrenia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Oral administration. Once per day. 0 None 2 153 68 153 View
Cariprazine 3.0 mg Oral administration. Once per day. 0 None 4 155 61 155 View
Cariprazine 6.0mg Oral administration. Once per day. 2 None 7 157 71 157 View
Aripiprazole 10.0 mg Oral administration. Once per day. 0 None 4 152 61 152 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Acute myocardial infarction SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 14.1 View
Schizophrenia, paranoid type SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Agitation NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Complete Suicide SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Dehydration SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 14.1 View
Ischemic stroke SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 14.1 View
Social stay hospitalization SYSTEMATIC_ASSESSMENT Surgical and medical procedures MedDRA 14.1 View
Transient ischemic attack SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 14.1 View
Psychotic disorder SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Schizophrenia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Supraventricular tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA 14.1 View
Artropod bite NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 14.1 View
Pneumonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 14.1 View
Bronchitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 14.1 View
Depression NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Toxicity to various agents SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 14.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Schizophrenia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Abdominal discomfort NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.1 View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.1 View
Vaginal Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.1 View
Akathisia NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 14.1 View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 14.1 View
Insomnia NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Anxiety NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View
Agitation NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 14.1 View